Your browser doesn't support javascript.
loading
Regional variation of effects of new antidiabetic medications in cardiovascular outcome trials.
Cotter, Gad; Davison, Beth A; Edwards, Christopher; Senger, Stefanie; Teerlink, John R; Zannad, Faiez; Nielsen, Olav Wendelboe; Metra, Marco; Mebazaa, Alexandre; Chioncel, Ovidiu; Greenberg, Barry H; Maggioni, Aldo P; Ertl, Georg; Sato, Naoki; Cohen-Solal, Alain.
Afiliação
  • Cotter G; Momentum Research Inc, Durham, North Carolina; Inserm U942 MASCOT, Paris, France. Electronic address: gadcotter@momentum-research.com.
  • Davison BA; Momentum Research Inc, Durham, North Carolina; Inserm U942 MASCOT, Paris, France.
  • Edwards C; Momentum Research Inc, Durham, North Carolina.
  • Senger S; Momentum Research Inc, Durham, North Carolina.
  • Teerlink JR; Section of Cardiology, San Francisco Veterans Affairs Medical Center and School of Medicine, University of California San Francisco,San Francisco, CA.
  • Zannad F; Inserm CIC-P 1433, Université de Lorraine, CHRU de Nancy, FCRIN INI-CRCT, Nancy, France.
  • Nielsen OW; Department of Cardiology, Bispebjerg Hospital, University of Copenhagen, Denmark.
  • Metra M; Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Italy.
  • Mebazaa A; Department of Anesthesiology and Critical Care Medicine, AP-HP, Saint Louis Lariboisière University Hospitals, Université de Paris, Paris, France.
  • Chioncel O; University of Medicine Carol Davila, Bucharest, Romania.
  • Greenberg BH; Division of Cardiology, University of California San Diego, California.
  • Maggioni AP; Associazione Nazionale Medici Cardiologi Ospedalien (ANMCO) Research Center, Florence, Italy.
  • Ertl G; Julius-Maximilians-Universität Würzburg, Germany.
  • Sato N; Cardiology and Intensive Care Unit, Nippon Medical School, Musashi-Kosugi Hospital, Kawasaki, Japan.
  • Cohen-Solal A; Service de Cardiologie, Hôpital Lariboisière, 75010 Paris, France.
Am Heart J ; 240: 73-80, 2021 10.
Article em En | MEDLINE | ID: mdl-34107289
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Diabetes Mellitus Tipo 2 / Receptor do Peptídeo Semelhante ao Glucagon 1 / Inibidores do Transportador 2 de Sódio-Glicose / Hipoglicemiantes Tipo de estudo: Diagnostic_studies / Systematic_reviews Limite: Humans Idioma: En Revista: Am Heart J Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Diabetes Mellitus Tipo 2 / Receptor do Peptídeo Semelhante ao Glucagon 1 / Inibidores do Transportador 2 de Sódio-Glicose / Hipoglicemiantes Tipo de estudo: Diagnostic_studies / Systematic_reviews Limite: Humans Idioma: En Revista: Am Heart J Ano de publicação: 2021 Tipo de documento: Article